Publication | Closed Access

Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment

Cannabis UseAntipsychotic TreatmentPsychiatryD2 DopaminePsychotic DisorderPsychopharmacologySchizophreniaNeuropharmacologyNeuropsychiatryA2a AdenosineSocial SciencesNeuroscienceNeurologyDopamineMedicineCannabinoidsPsychopathologyCannabis